Authors: Lam, PYP Breakefield, XO

Citation: Pyp. Lam et Xo. Breakefield, Potential of gene therapy for brain tumors, HUM MOL GEN, 10(7), 2001, pp. 777-787

Authors: Lam, PYP Breakefield, XO

Citation: Pyp. Lam et Xo. Breakefield, Hybrid vector designs to control the delivery, fate and expression of transgenes, J GENE MED, 2(6), 2000, pp. 395-408

Authors: Di Tomaso, E Pang, JCS Ng, HK Lam, PYP Tian, XX Suen, KW Hui, ABY Hjelm, NM

Citation: E. Di Tomaso et al., Establishment and characterization of a human cell line from paediatric cerebellar glioblastoma multiforme, NEUROP AP N, 26(1), 2000, pp. 22-30

Authors: Lam, PYP Ditomaso, E Ng, HK Pang, JCS Roussel, MF Hjelm, NM

Citation: Pyp. Lam et al., Expression of p19(INK4d), CDK4, CDK6 in glioblastoma multiforme, BR J NEUROS, 14(1), 2000, pp. 28-32

Authors: Lam, PYP Sublett, JE Hollenbach, AD Roussel, MF

Citation: Pyp. Lam et al., The oncogenic potential of the Pax3-FKHR fusion protein requires the Pax3 homeodomain recognition helix but not the Pax3 paired-box DNA binding domain (vol 19, pg 594, 1999), MOL CELL B, 19(10), 1999, pp. 7287-7287

Authors: Lam, PYP Sublett, JE Hollenbach, AD Roussel, MF

Citation: Pyp. Lam et al., The oncogenic potential of the Pax3-FKHR fusion protein requires the Pax3 homeodomain recognition helix but not the Pax3 paired-box DNA binding domain, MOL CELL B, 19(1), 1999, pp. 594-601